The core activity of Cerbios-Pharma SA is the development and manufacturing of pharmaceutical active ingredients (APIs), in particular highly potent active ingredients (HPAPIs), antibody-drug conjugates (ADCs) and biologics, as a Contract Development and Manufacturing Organization (CDMO).
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered7
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Process and analytical development, scale-up and clinical supply, industrial validation, commercial manufacturing and comprehensive CMC regulatory support for pharmaceutical active ingredients and biotherapeutics.
HPAPIs
Development and manufacturing of high potency APIs under cGMP conditions, including containment per SafeBridge Category 3 and 4, process development, scale-up, validation and regulatory support.
ADCs
Development and manufacturing of antibody drug conjugates and their components, including mAb, payload and conjugation, from early phase to commercial delivery.
Proteins & Antibodies
Tailor-made development and manufacturing programs for recombinant proteins and monoclonal antibodies, from cloning and cell banks through cGMP production and regulatory support.
Drug Substances
Commercially available active ingredients from vitamin D derivatives, reduced folates and other pharmaceutical substances with different registration dossiers.
Knowledge
No knowledge articles yet
Once Cerbios-Pharma SA has claimed this profile, we'll publish editorial articles and case studies here together.